Real-world drug utilisation of nintedanib and pirfenidone for interstitial lung disease in Singapore

Ann Acad Med Singap. 2026 Apr 22;55(7):392-395. doi: 10.47102/annals-acadmedsg.2026121.

Authors

Tingfeng Lee¹, Yi Jing Lim¹, Andrew Yunkai Li², Ziqin Ng², Zhikui Chrystal Huang³, Gin Tsen Chai²

Affiliations

¹ Division of Pharmacy, Tan Tock Seng Hospital, Singapore.
² Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore.
³ Clinical Research & Innovation Office, Tan Tock Seng Hospital, Singapore.

PMID: 42037102
DOI: 10.47102/annals-acadmedsg.2026121

No abstract available

Keywords: Singapore; antifibrotic; interstitial lung disease; nintedanib; pirfenidone; respiratory medicine.

Publication types

Letter